Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2015 1
2016 1
2017 2
2018 2
2019 2
2020 1
2021 6
2022 9
2023 12
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
A case of anti-Th/To antibody-positive interstitial lung disease and pulmonary arterial hypertension that does not meet the classification criteria of systemic sclerosis: Comment on the article by Moschetti et al.
Sakaida E, Yamashita Y, Muro Y, Sawa M, Mitsuma T, Akiyama M. Sakaida E, et al. Among authors: yamashita y. Clin Exp Rheumatol. 2024 Feb 13. doi: 10.55563/clinexprheumatol/7ikx0g. Online ahead of print. Clin Exp Rheumatol. 2024. PMID: 38372709 No abstract available.
Correlation of serum allergen-specific IgE with total serum IgE and IgE specific to other allergens in Atopic dermatitis patients.
Akashi N, Ogawa-Momohara M, Taki T, Fukaura R, Wakahara K, Kamiya S, Yamashita Y, Koizumi H, Takeichi T, Muro Y, Akiyama M. Akashi N, et al. Among authors: yamashita y. J Eur Acad Dermatol Venereol. 2024 Feb 19. doi: 10.1111/jdv.19872. Online ahead of print. J Eur Acad Dermatol Venereol. 2024. PMID: 38372194 No abstract available.
Panniculitis on the trunk as a possible characteristic feature of anti-SAE1/2 antibody-positive dermatomyositis: A possible cutaneous manifestation of treatment resistance.
Tago M, Koizumi H, Kamiya S, Akashi N, Miyazaki A, Yamashita Y, Ogawa-Momohara M, Takeichi T, Muro Y, Akiyama M. Tago M, et al. Among authors: yamashita y. J Dermatol. 2024 Feb 16. doi: 10.1111/1346-8138.17128. Online ahead of print. J Dermatol. 2024. PMID: 38362647 No abstract available.
ELISA detection of anti-eIF2B antibodies in Japanese patients with systemic sclerosis.
Koizumi H, Yamano Y, Muro Y, Fukaura R, Yamashita Y, Kamiya S, Akashi N, Ogawa-Momohara M, Takeichi T, Kondoh Y, Akiyama M. Koizumi H, et al. Among authors: yamashita y. Rheumatology (Oxford). 2023 Dec 4:kead649. doi: 10.1093/rheumatology/kead649. Online ahead of print. Rheumatology (Oxford). 2023. PMID: 38048623 No abstract available.
Increased Janus kinase activation in cutaneous vasculitis.
Ebata A, Ogawa-Momohara M, Fukaura R, Yamashita Y, Koizumi H, Takeichi T, Muro Y, Akiyama M. Ebata A, et al. Among authors: yamashita y. J Am Acad Dermatol. 2024 Mar;90(3):627-629. doi: 10.1016/j.jaad.2023.10.056. Epub 2023 Nov 3. J Am Acad Dermatol. 2024. PMID: 37924954 Free article. No abstract available.
Systemic administration of clinical-grade multilineage-differentiating stress-enduring cells ameliorates hypoxic-ischemic brain injury in neonatal rats.
Ueda K, Sato Y, Shimizu S, Suzuki T, Onoda A, Miura R, Go S, Mimatsu H, Kitase Y, Yamashita Y, Irie K, Tsuji M, Mishima K, Mizuno M, Takahashi Y, Dezawa M, Hayakawa M. Ueda K, et al. Among authors: yamashita y. Sci Rep. 2023 Sep 11;13(1):14958. doi: 10.1038/s41598-023-41026-3. Sci Rep. 2023. PMID: 37696826 Free PMC article.
Allergen-specific IgG4 increase in atopic dermatitis with long-term dupilumab use.
Ogawa-Momohara M, Muro Y, Murase C, Taki T, Tanahashi K, Yamashita Y, Koizumi H, Fukaura R, Takeichi T, Akiyama M. Ogawa-Momohara M, et al. Among authors: yamashita y. Br J Dermatol. 2023 Sep 15;189(4):472-474. doi: 10.1093/bjd/ljad207. Br J Dermatol. 2023. PMID: 37368821 No abstract available.
35 results